UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

The Effects of Lovaza® in Acute Myocardial Infarction

Phase 1

Terminated

Conditions: Myocardial Infarction

Interventions: Drug: Lovaza®
Drug: The placebo contained 1 gram of corn oil in each capsule.

First Posted Date: 2010-07-01

Last Posted Date: 2017-11-06

Lead Sponsor: University of Rochester

Target Recruit Count: 4

Registration Number: NCT01155336

Locations: 🇺🇸
University or Rochester, Rochester, New York, United States

Pilot Study of Fosamax in Spinal Cord Injury

Not Applicable

Terminated

Conditions: Spinal Cord Injury
Osteoporosis

Interventions: Drug: Fosamax
Drug: Placebo

First Posted Date: 2010-05-27

Last Posted Date: 2016-01-29

Lead Sponsor: University of Rochester

Target Recruit Count: 1

Registration Number: NCT01131884

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States
🇺🇸
University of Rochester Physical Medicine and Rehabilitation, Rochester, New York, United States

Non-invasive Tear Film Dynamic Measurements in Normal, MGD and ADDE Subjects After Saline Instillation

Not Applicable

Completed

Conditions: Meibomium Gland Dysfunction
Aqueous Deficient Dry Eye

Interventions: Behavioral: Subjective Questionnaire
Procedure: Measurement with wavefront sensor (right eye, then left eye)
Drug: Instill Saline Drop

First Posted Date: 2010-05-21

Last Posted Date: 2015-08-07

Lead Sponsor: University of Rochester

Target Recruit Count: 15

Registration Number: NCT01128049

Locations: 🇺🇸
The Flaum Eye Institute-University of Rochester, Rochester, New York, United States

National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study

Completed

Conditions: Psoriatic Arthritis

Interventions: Drug: Anti-TNF
Drug: Methotrexate

First Posted Date: 2010-05-14

Last Posted Date: 2015-09-21

Lead Sponsor: University of Rochester

Target Recruit Count: 22

Registration Number: NCT01123265

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

A Pilot Study to Improve Preventive Asthma Care for Urban Adolescents

Not Applicable

Completed

Conditions: Asthma

Interventions: Behavioral: Intervention

First Posted Date: 2010-04-19

Last Posted Date: 2014-08-01

Lead Sponsor: University of Rochester

Target Recruit Count: 30

Registration Number: NCT01106326

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

A Multifaceted Prompting Intervention for Urban Children With Asthma

Not Applicable

Completed

Conditions: Asthma

Interventions: Behavioral: Multifaceted Prompting Intervention MPI

First Posted Date: 2010-04-16

Last Posted Date: 2016-02-08

Lead Sponsor: University of Rochester

Target Recruit Count: 638

Registration Number: NCT01105754

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Temporal Pattern of Circulating DNA for Patients Receiving Irradiation

Terminated

Conditions: Radiation

First Posted Date: 2010-04-06

Last Posted Date: 2015-06-02

Lead Sponsor: University of Rochester

Target Recruit Count: 13

Registration Number: NCT01099020

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA)

Completed

Conditions: Rheumatoid Arthritis

First Posted Date: 2010-04-02

Last Posted Date: 2015-09-21

Lead Sponsor: University of Rochester

Target Recruit Count: 5

Registration Number: NCT01098201

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children

Phase 4

Withdrawn

Conditions: 2009 H1N1 Influenza

Interventions: Biological: Influenza A (H1N1) 2009 Monovalent Vaccine/ Influenza A (H1N1) Monovalent Vaccine Live
Biological: Influenza A (H1N1) 2009 Monovalent Vaccine
Biological: Live Attenuated H1N1 Influenza Vaccine

First Posted Date: 2010-04-02

Last Posted Date: 2015-09-24

Lead Sponsor: University of Rochester

Registration Number: NCT01097941

Locations: 🇺🇸
University of Rochester Medical Center, Vaccine Research Unit Room 3-5000, Rochester, New York, United States

Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy

Phase 2

Completed

Conditions: Insomnia
Fatigue
Breast Cancer

Interventions: Drug: armodafinil
Drug: Placebo Comparator
Behavioral: CBT-I

First Posted Date: 2010-03-24

Last Posted Date: 2017-02-09

Lead Sponsor: University of Rochester

Target Recruit Count: 138

Registration Number: NCT01091974

Locations: 🇺🇸
University of Rochester James P. Wilmot Cancer Center, Rochester, New York, United States
🇺🇸
Behavioral Sleep Medicine Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy